Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Seres Therapeutics: Q3 Earnings Snapshot

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.7318 (-10.09%)
Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

MCRB : 0.7318 (-10.09%)
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

MCRB : 0.7318 (-10.09%)
Seres Therapeutics: Q2 Earnings Snapshot

Seres Therapeutics: Q2 Earnings Snapshot

MCRB : 0.7318 (-10.09%)
Seres Therapeutics: Q1 Earnings Snapshot

Seres Therapeutics: Q1 Earnings Snapshot

MCRB : 0.7318 (-10.09%)
Seres Therapeutics: Q3 Earnings Snapshot

Seres Therapeutics: Q3 Earnings Snapshot

MCRB : 0.7318 (-10.09%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 24.22 (-0.82%)
FHTX : 7.72 (-1.78%)
MRNA : 38.25 (+3.55%)
OMGA : 0.7760 (-1.80%)
SANA : 2.35 (-7.11%)
MCRB : 0.7318 (-10.09%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 24.22 (-0.82%)
FHTX : 7.72 (-1.78%)
MRNA : 38.25 (+3.55%)
OMGA : 0.7760 (-1.80%)
SANA : 2.35 (-7.11%)
MCRB : 0.7318 (-10.09%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 24.22 (-0.82%)
FHTX : 7.72 (-1.78%)
MRNA : 38.25 (+3.55%)
OMGA : 0.7760 (-1.80%)
SANA : 2.35 (-7.11%)
MCRB : 0.7318 (-10.09%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 24.22 (-0.82%)
FHTX : 7.72 (-1.78%)
MRNA : 38.25 (+3.55%)
OMGA : 0.7760 (-1.80%)
SANA : 2.35 (-7.11%)
MCRB : 0.7318 (-10.09%)

Barchart Exclusives

S&P Futures Tick Lower Ahead of U.S. PMI Data
December S&P 500 E-Mini futures (ESZ24) are trending down -0.24% this morning as weak Eurozone PMI data cast doubt on the health of the global economy, while investors braced for U.S. business activity data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar